Novel motif:169
From FANTOM5_SSTAR
name: | motif169_GCCTGGCC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0034505 | tooth mineralization | 2.044831e-20 |
GO:0060346 | bone trabecula formation | 1.235340e-18 |
GO:0032964 | collagen biosynthetic process | 1.884869e-18 |
GO:0006544 | glycine metabolic process | 5.133393e-16 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 9.304262e-16 |
GO:0060343 | trabecula formation | 3.127273e-15 |
GO:0061383 | trabecula morphogenesis | 1.080705e-14 |
GO:0070208 | protein heterotrimerization | 3.527488e-14 |
GO:0001957 | intramembranous ossification | 3.565337e-14 |
GO:0045112 | integrin biosynthetic process | 1.026234e-13 |
GO:0032863 | activation of Rac GTPase activity | 2.285702e-12 |
GO:0010624 | regulation of Schwann cell proliferation | 3.851880e-12 |
GO:0045217 | cell-cell junction maintenance | 1.099334e-11 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 3.004794e-11 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 4.405783e-11 |
GO:0043503 | skeletal muscle fiber adaptation | 6.586308e-11 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 7.121808e-11 |
GO:0046655 | folic acid metabolic process | 1.776576e-10 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 1.908502e-10 |
GO:0032383 | regulation of intracellular cholesterol transport | 2.185450e-10 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 2.722965e-10 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 2.982277e-10 |
GO:0032793 | positive regulation of CREB transcription factor activity | 4.956680e-10 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 8.539334e-10 |
GO:0035814 | negative regulation of renal sodium excretion | 8.649524e-10 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 9.255152e-10 |
GO:0071956 | cellular component maintenance at cellular level | 1.066993e-9 |
GO:0032012 | regulation of ARF protein signal transduction | 1.072194e-9 |
GO:0006545 | glycine biosynthetic process | 1.384080e-9 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.644403e-9 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 3.181368e-9 |
GO:0043088 | regulation of Cdc42 GTPase activity | 4.237337e-9 |
GO:0035313 | wound healing, spreading of epidermal cells | 4.760228e-9 |
GO:0051764 | actin crosslink formation | 5.043327e-9 |
GO:0016056 | rhodopsin mediated signaling pathway | 5.863975e-9 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 6.139837e-9 |
GO:0016458 | gene silencing | 6.193088e-9 |
GO:0007386 | compartment pattern specification | 6.353179e-9 |
GO:0070483 | detection of hypoxia | 8.744670e-9 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 9.077464e-9 |
GO:0060482 | lobar bronchus development | 9.479160e-9 |
GO:0035470 | positive regulation of vascular wound healing | 1.373786e-8 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 1.415152e-8 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 1.423010e-8 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 1.423010e-8 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 1.568118e-8 |
GO:0032425 | positive regulation of mismatch repair | 2.124565e-8 |
GO:0060708 | spongiotrophoblast differentiation | 2.184494e-8 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 2.539179e-8 |
GO:0007635 | chemosensory behavior | 2.627199e-8 |
GO:0014028 | notochord formation | 3.024988e-8 |
GO:0046626 | regulation of insulin receptor signaling pathway | 3.468117e-8 |
GO:0071071 | regulation of phospholipid biosynthetic process | 4.163823e-8 |
GO:0051291 | protein heterooligomerization | 4.711150e-8 |
GO:0010625 | positive regulation of Schwann cell proliferation | 4.753289e-8 |
GO:0042074 | cell migration involved in gastrulation | 6.583476e-8 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 7.848037e-8 |
GO:0002149 | hypochlorous acid biosynthetic process | 8.004846e-8 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 9.408224e-8 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 9.701618e-8 |
GO:0003009 | skeletal muscle contraction | 9.926720e-8 |
GO:0032423 | regulation of mismatch repair | 1.046833e-7 |
GO:0033326 | cerebrospinal fluid secretion | 1.338379e-7 |
GO:0051488 | activation of anaphase-promoting complex activity | 1.384404e-7 |
GO:0002019 | regulation of renal output by angiotensin | 1.708372e-7 |
GO:0002679 | respiratory burst involved in defense response | 1.729761e-7 |
GO:0022009 | central nervous system vasculogenesis | 2.105411e-7 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 2.204287e-7 |
GO:0044319 | wound healing, spreading of cells | 2.446193e-7 |
GO:0072060 | outer medullary collecting duct development | 2.495661e-7 |
GO:0072061 | inner medullary collecting duct development | 2.495661e-7 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 2.495661e-7 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 2.898590e-7 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 3.356069e-7 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 3.740058e-7 |
GO:0060534 | trachea cartilage development | 3.757393e-7 |
GO:0021526 | medial motor column neuron differentiation | 3.870312e-7 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 3.870312e-7 |
GO:0006012 | galactose metabolic process | 4.025184e-7 |
GO:0032312 | regulation of ARF GTPase activity | 4.594910e-7 |
GO:0060419 | heart growth | 4.800913e-7 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 5.756424e-7 |
GO:0009069 | serine family amino acid metabolic process | 5.862678e-7 |
GO:0008078 | mesodermal cell migration | 6.487725e-7 |
GO:0048320 | axial mesoderm formation | 6.747422e-7 |
GO:0051645 | Golgi localization | 6.771282e-7 |
GO:0043487 | regulation of RNA stability | 7.713605e-7 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 8.181526e-7 |
GO:0018293 | protein-FAD linkage | 8.309421e-7 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 8.309421e-7 |
GO:0014807 | regulation of somitogenesis | 8.406556e-7 |
GO:0006337 | nucleosome disassembly | 8.764342e-7 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 9.057967e-7 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 9.090792e-7 |
GO:0050685 | positive regulation of mRNA processing | 1.092042e-6 |
GO:0055017 | cardiac muscle tissue growth | 1.094426e-6 |
GO:0032862 | activation of Rho GTPase activity | 1.280679e-6 |
GO:0006261 | DNA-dependent DNA replication | 1.316081e-6 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.317329e-6 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 1.326688e-6 |
GO:0060251 | regulation of glial cell proliferation | 1.458516e-6 |
GO:0060035 | notochord cell development | 1.529582e-6 |
GO:0043488 | regulation of mRNA stability | 1.586750e-6 |
GO:0007506 | gonadal mesoderm development | 1.967478e-6 |
GO:0042274 | ribosomal small subunit biogenesis | 1.991284e-6 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 2.049137e-6 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 2.277363e-6 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 2.277363e-6 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 2.277363e-6 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 2.277363e-6 |
GO:0019388 | galactose catabolic process | 2.406462e-6 |
GO:0006349 | regulation of gene expression by genetic imprinting | 2.435476e-6 |
GO:0060253 | negative regulation of glial cell proliferation | 2.471088e-6 |
GO:0033002 | muscle cell proliferation | 2.471088e-6 |
GO:0071300 | cellular response to retinoic acid | 2.804226e-6 |
GO:0060535 | trachea cartilage morphogenesis | 3.069188e-6 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 3.208402e-6 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 3.375479e-6 |
GO:0071299 | cellular response to vitamin A | 3.443678e-6 |
GO:0006264 | mitochondrial DNA replication | 3.897910e-6 |
GO:0006984 | ER-nucleus signaling pathway | 3.975667e-6 |
GO:0043314 | negative regulation of neutrophil degranulation | 4.062631e-6 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 4.115950e-6 |
GO:0006342 | chromatin silencing | 4.277426e-6 |
GO:0005984 | disaccharide metabolic process | 4.730664e-6 |
GO:0000028 | ribosomal small subunit assembly | 4.784327e-6 |
GO:0002432 | granuloma formation | 5.066012e-6 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 5.509958e-6 |
GO:0071549 | cellular response to dexamethasone stimulus | 5.509958e-6 |
GO:0001880 | Mullerian duct regression | 5.518682e-6 |
GO:0030037 | actin filament reorganization involved in cell cycle | 5.959157e-6 |
GO:0032506 | cytokinetic process | 6.277670e-6 |
GO:0010626 | negative regulation of Schwann cell proliferation | 7.040573e-6 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 7.142924e-6 |
GO:0031365 | N-terminal protein amino acid modification | 7.547575e-6 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 7.610004e-6 |
GO:0043628 | ncRNA 3'-end processing | 7.924530e-6 |
GO:0060707 | trophoblast giant cell differentiation | 8.489657e-6 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 8.735291e-6 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 8.857959e-6 |
GO:0015879 | carnitine transport | 8.962957e-6 |
GO:0051321 | meiotic cell cycle | 9.551441e-6 |
GO:0032972 | regulation of muscle filament sliding speed | 1.000059e-5 |
GO:2000143 | negative regulation of transcription initiation, DNA-dependent | 1.009527e-5 |
GO:0042866 | pyruvate biosynthetic process | 1.027897e-5 |
GO:0071316 | cellular response to nicotine | 1.031848e-5 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 1.045464e-5 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 1.133603e-5 |
GO:0006289 | nucleotide-excision repair | 1.166752e-5 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 1.241067e-5 |
GO:0044342 | type B pancreatic cell proliferation | 1.241067e-5 |
GO:0007141 | male meiosis I | 1.245805e-5 |
GO:0032049 | cardiolipin biosynthetic process | 1.401681e-5 |
GO:0007051 | spindle organization | 1.549288e-5 |
GO:0018208 | peptidyl-proline modification | 1.784877e-5 |
GO:0060456 | positive regulation of digestive system process | 1.870516e-5 |
GO:0048144 | fibroblast proliferation | 1.885612e-5 |
GO:0031047 | gene silencing by RNA | 1.895021e-5 |
GO:0060712 | spongiotrophoblast layer development | 1.910501e-5 |
GO:0006546 | glycine catabolic process | 1.946528e-5 |
GO:0034214 | protein hexamerization | 2.098563e-5 |
GO:0060038 | cardiac muscle cell proliferation | 2.345415e-5 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 2.353166e-5 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 2.427031e-5 |
GO:0010893 | positive regulation of steroid biosynthetic process | 2.532396e-5 |
GO:0032042 | mitochondrial DNA metabolic process | 2.703776e-5 |
GO:0000305 | response to oxygen radical | 2.717279e-5 |
GO:2000210 | positive regulation of anoikis | 2.840918e-5 |
GO:0072109 | glomerular mesangium development | 2.910455e-5 |
GO:0048242 | epinephrine secretion | 2.944784e-5 |
GO:0046724 | oxalic acid secretion | 2.944784e-5 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 2.944784e-5 |
GO:0045835 | negative regulation of meiosis | 2.991543e-5 |
GO:0048702 | embryonic neurocranium morphogenesis | 3.232237e-5 |
GO:0015891 | siderophore transport | 3.389446e-5 |
GO:0045814 | negative regulation of gene expression, epigenetic | 3.765748e-5 |
GO:0000413 | protein peptidyl-prolyl isomerization | 3.817621e-5 |
GO:0071514 | genetic imprinting | 3.838427e-5 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 3.903394e-5 |
GO:0000084 | S phase of mitotic cell cycle | 3.997182e-5 |
GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 4.120462e-5 |
GO:0007126 | meiosis | 4.199443e-5 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 4.217520e-5 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 4.217520e-5 |
GO:0009386 | translational attenuation | 4.217520e-5 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 4.275500e-5 |
GO:0048255 | mRNA stabilization | 4.567391e-5 |
GO:0032007 | negative regulation of TOR signaling cascade | 4.630794e-5 |
GO:0030421 | defecation | 4.695916e-5 |
GO:0071585 | detoxification of cadmium ion | 4.734351e-5 |
GO:0032094 | response to food | 5.133105e-5 |
GO:0031064 | negative regulation of histone deacetylation | 5.158530e-5 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 5.172499e-5 |
GO:0009071 | serine family amino acid catabolic process | 5.423953e-5 |
GO:0007283 | spermatogenesis | 5.842624e-5 |
GO:0007509 | mesoderm migration involved in gastrulation | 5.869584e-5 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 5.926386e-5 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 6.321379e-5 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 6.364131e-5 |
GO:0070574 | cadmium ion transmembrane transport | 6.403408e-5 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 6.416923e-5 |
GO:0035307 | positive regulation of protein dephosphorylation | 6.875101e-5 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 7.016065e-5 |
GO:0048243 | norepinephrine secretion | 7.016065e-5 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 7.243754e-5 |
GO:0045940 | positive regulation of steroid metabolic process | 7.270982e-5 |
GO:0031017 | exocrine pancreas development | 7.419231e-5 |
GO:0032984 | macromolecular complex disassembly | 7.579103e-5 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 7.844248e-5 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 8.535648e-5 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 8.535648e-5 |
GO:0031468 | nuclear envelope reassembly | 8.661023e-5 |
GO:0001546 | preantral ovarian follicle growth | 8.661023e-5 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 8.815887e-5 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 9.067560e-5 |
GO:0035306 | positive regulation of dephosphorylation | 9.638314e-5 |
GO:0010874 | regulation of cholesterol efflux | 9.857200e-5 |
GO:0015884 | folic acid transport | 9.997622e-5 |
GO:0051693 | actin filament capping | 1.009759e-4 |
GO:0007341 | penetration of zona pellucida | 1.088566e-4 |
GO:0007212 | dopamine receptor signaling pathway | 1.093790e-4 |
GO:0022617 | extracellular matrix disassembly | 1.094308e-4 |
GO:0043585 | nose morphogenesis | 1.127606e-4 |
GO:0050902 | leukocyte adhesive activation | 1.146436e-4 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 1.146436e-4 |
GO:0035105 | sterol regulatory element binding protein import into nucleus | 1.146436e-4 |
GO:0010875 | positive regulation of cholesterol efflux | 1.148625e-4 |
GO:0032526 | response to retinoic acid | 1.157900e-4 |
GO:0034976 | response to endoplasmic reticulum stress | 1.241442e-4 |
GO:0045820 | negative regulation of glycolysis | 1.270252e-4 |
GO:0006438 | valyl-tRNA aminoacylation | 1.310071e-4 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 1.382009e-4 |
GO:0048570 | notochord morphogenesis | 1.387578e-4 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.387578e-4 |
GO:0022038 | corpus callosum development | 1.450374e-4 |
GO:0032376 | positive regulation of cholesterol transport | 1.482604e-4 |
GO:0007109 | cytokinesis, completion of separation | 1.550814e-4 |
GO:0015804 | neutral amino acid transport | 1.566610e-4 |
GO:0072332 | signal transduction by p53 class mediator resulting in induction of apoptosis | 1.620925e-4 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 1.629047e-4 |
GO:0051013 | microtubule severing | 1.629047e-4 |
GO:0051586 | positive regulation of dopamine uptake | 1.638172e-4 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 1.643920e-4 |
GO:2000573 | positive regulation of DNA biosynthetic process | 1.664698e-4 |
GO:0051532 | regulation of NFAT protein import into nucleus | 1.666558e-4 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 1.666558e-4 |
GO:0043313 | regulation of neutrophil degranulation | 1.715519e-4 |
GO:0051220 | cytoplasmic sequestering of protein | 1.715630e-4 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.719766e-4 |
GO:0043181 | vacuolar sequestering | 1.778602e-4 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 1.778602e-4 |
GO:0005985 | sucrose metabolic process | 1.778602e-4 |
GO:0000023 | maltose metabolic process | 1.778602e-4 |
GO:0030327 | prenylated protein catabolic process | 1.785874e-4 |
GO:0045090 | retroviral genome replication | 1.785874e-4 |
GO:0030309 | poly-N-acetyllactosamine metabolic process | 1.785874e-4 |
GO:0000303 | response to superoxide | 1.811743e-4 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.831706e-4 |
GO:0033505 | floor plate morphogenesis | 1.846446e-4 |
GO:0051414 | response to cortisol stimulus | 1.892923e-4 |
GO:0035967 | cellular response to topologically incorrect protein | 1.908598e-4 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 1.990220e-4 |
GO:0032796 | uropod organization | 2.057759e-4 |
GO:0070307 | lens fiber cell development | 2.064941e-4 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 2.065854e-4 |
GO:0009451 | RNA modification | 2.078720e-4 |
GO:0060236 | regulation of mitotic spindle organization | 2.115103e-4 |
GO:0007021 | tubulin complex assembly | 2.120730e-4 |
GO:0006353 | transcription termination, DNA-dependent | 2.162255e-4 |
GO:0031125 | rRNA 3'-end processing | 2.182042e-4 |
GO:0040030 | regulation of molecular function, epigenetic | 2.182042e-4 |
GO:0002036 | regulation of L-glutamate transport | 2.242842e-4 |
GO:0000185 | activation of MAPKKK activity | 2.321810e-4 |
GO:0060997 | dendritic spine morphogenesis | 2.403175e-4 |
GO:0006760 | folic acid-containing compound metabolic process | 2.431791e-4 |
GO:0097152 | mesenchymal cell apoptosis | 2.434657e-4 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 2.434657e-4 |
GO:0060982 | coronary artery morphogenesis | 2.434657e-4 |
GO:0006281 | DNA repair | 2.436452e-4 |
GO:0019048 | virus-host interaction | 2.483373e-4 |
GO:0060014 | granulosa cell differentiation | 2.557366e-4 |
GO:0043096 | purine base salvage | 2.557366e-4 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 2.562132e-4 |
GO:0046778 | modification by virus of host mRNA processing | 2.611409e-4 |
GO:0030046 | parallel actin filament bundle assembly | 2.611409e-4 |
GO:0009440 | cyanate catabolic process | 2.611409e-4 |
GO:0009650 | UV protection | 2.640581e-4 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 2.775641e-4 |
GO:0070194 | synaptonemal complex disassembly | 2.775641e-4 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 2.792765e-4 |
GO:0010994 | free ubiquitin chain polymerization | 2.869424e-4 |
GO:0006420 | arginyl-tRNA aminoacylation | 2.869424e-4 |
GO:0001885 | endothelial cell development | 2.893318e-4 |
GO:0000212 | meiotic spindle organization | 2.904280e-4 |
GO:0045218 | zonula adherens maintenance | 3.001685e-4 |
GO:0006772 | thiamine metabolic process | 3.060105e-4 |
GO:0019264 | glycine biosynthetic process from serine | 3.062170e-4 |
GO:0060350 | endochondral bone morphogenesis | 3.205785e-4 |
GO:0090239 | regulation of histone H4 acetylation | 3.438106e-4 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 3.451063e-4 |
GO:0097107 | postsynaptic density assembly | 3.451063e-4 |
GO:0002077 | acrosome matrix dispersal | 3.652463e-4 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 3.696234e-4 |
GO:0072205 | metanephric collecting duct development | 3.720497e-4 |
GO:0090205 | positive regulation of cholesterol metabolic process | 3.728007e-4 |
GO:0090241 | negative regulation of histone H4 acetylation | 3.761492e-4 |
GO:0051781 | positive regulation of cell division | 3.876916e-4 |
GO:0071280 | cellular response to copper ion | 3.911706e-4 |
GO:0006419 | alanyl-tRNA aminoacylation | 3.911706e-4 |
GO:0021508 | floor plate formation | 3.911706e-4 |
GO:0046939 | nucleotide phosphorylation | 3.969335e-4 |
GO:0001842 | neural fold formation | 4.053825e-4 |
GO:0006268 | DNA unwinding involved in replication | 4.234592e-4 |
GO:0010889 | regulation of sequestering of triglyceride | 4.251824e-4 |
GO:0045838 | positive regulation of membrane potential | 4.264120e-4 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 4.314306e-4 |
GO:0071732 | cellular response to nitric oxide | 4.331943e-4 |
GO:0009070 | serine family amino acid biosynthetic process | 4.332607e-4 |
GO:0021523 | somatic motor neuron differentiation | 4.391612e-4 |
GO:0006360 | transcription from RNA polymerase I promoter | 4.421061e-4 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 4.448804e-4 |
GO:0014909 | smooth muscle cell migration | 4.462874e-4 |
GO:0048194 | Golgi vesicle budding | 4.533429e-4 |
GO:0032864 | activation of Cdc42 GTPase activity | 4.650910e-4 |
GO:0030513 | positive regulation of BMP signaling pathway | 4.675363e-4 |
GO:0002074 | extraocular skeletal muscle development | 4.767124e-4 |
GO:0046878 | positive regulation of saliva secretion | 4.767124e-4 |
GO:0010225 | response to UV-C | 4.835939e-4 |
GO:0060290 | transdifferentiation | 4.861686e-4 |
GO:0002268 | follicular dendritic cell differentiation | 4.927281e-4 |
GO:0070206 | protein trimerization | 4.966108e-4 |
GO:0070947 | neutrophil mediated killing of fungus | 4.993373e-4 |
GO:0031330 | negative regulation of cellular catabolic process | 5.027163e-4 |
GO:0007140 | male meiosis | 5.089273e-4 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 5.239306e-4 |
GO:0048319 | axial mesoderm morphogenesis | 5.414353e-4 |
GO:0045651 | positive regulation of macrophage differentiation | 5.444103e-4 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 5.475731e-4 |
GO:0071731 | response to nitric oxide | 5.484601e-4 |
GO:0001881 | receptor recycling | 5.555944e-4 |
GO:0019430 | removal of superoxide radicals | 5.557454e-4 |
GO:0048241 | epinephrine transport | 5.645346e-4 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 5.673833e-4 |
GO:0032415 | regulation of sodium:hydrogen antiporter activity | 5.743983e-4 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 5.823702e-4 |
GO:0032205 | negative regulation of telomere maintenance | 5.873925e-4 |
GO:0046533 | negative regulation of photoreceptor cell differentiation | 5.997728e-4 |
GO:0043932 | ossification involved in bone remodeling | 6.070178e-4 |
GO:0072668 | tubulin complex biogenesis | 6.236990e-4 |
GO:0034623 | cellular macromolecular complex disassembly | 6.350666e-4 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 6.470774e-4 |
GO:0015695 | organic cation transport | 6.528042e-4 |
GO:0006308 | DNA catabolic process | 6.578339e-4 |
GO:0046607 | positive regulation of centrosome cycle | 6.642656e-4 |
GO:0045472 | response to ether | 6.642656e-4 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 6.642656e-4 |
GO:0035499 | carnosine biosynthetic process | 6.642656e-4 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 6.662087e-4 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 6.764399e-4 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 6.779560e-4 |
GO:0031129 | inductive cell-cell signaling | 6.837252e-4 |
GO:0051955 | regulation of amino acid transport | 6.921616e-4 |
GO:0030835 | negative regulation of actin filament depolymerization | 6.963289e-4 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 7.199259e-4 |
GO:0046755 | non-lytic virus budding | 7.253683e-4 |
GO:0090232 | positive regulation of spindle checkpoint | 7.358050e-4 |
GO:0043094 | cellular metabolic compound salvage | 7.385647e-4 |
GO:0046604 | positive regulation of mitotic centrosome separation | 7.500503e-4 |
GO:0060377 | negative regulation of mast cell differentiation | 7.500503e-4 |
GO:0045403 | negative regulation of interleukin-4 biosynthetic process | 7.500503e-4 |
GO:0070625 | zymogen granule exocytosis | 7.500503e-4 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 7.500503e-4 |
GO:0002295 | T-helper cell lineage commitment | 7.500503e-4 |
GO:0003192 | mitral valve formation | 7.500503e-4 |
GO:0003195 | tricuspid valve formation | 7.500503e-4 |
GO:0042723 | thiamine-containing compound metabolic process | 7.514985e-4 |
GO:0015816 | glycine transport | 7.514985e-4 |
GO:0042760 | very long-chain fatty acid catabolic process | 7.561447e-4 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 7.705176e-4 |
GO:0060349 | bone morphogenesis | 7.772503e-4 |
GO:0043491 | protein kinase B signaling cascade | 7.772696e-4 |
GO:0006369 | termination of RNA polymerase II transcription | 8.083711e-4 |
GO:0010711 | negative regulation of collagen catabolic process | 8.272870e-4 |
GO:0060313 | negative regulation of blood vessel remodeling | 8.272870e-4 |
GO:0060311 | negative regulation of elastin catabolic process | 8.272870e-4 |
GO:0010703 | negative regulation of histolysis | 8.272870e-4 |
GO:0000917 | barrier septum formation | 8.272870e-4 |
GO:0008065 | establishment of blood-nerve barrier | 8.272870e-4 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 8.338538e-4 |
GO:0000920 | cytokinetic cell separation | 8.357028e-4 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 8.357028e-4 |
GO:0018023 | peptidyl-lysine trimethylation | 8.564082e-4 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 8.628152e-4 |
GO:0010897 | negative regulation of triglyceride catabolic process | 8.628152e-4 |
GO:0072110 | glomerular mesangial cell proliferation | 8.695299e-4 |
GO:0007063 | regulation of sister chromatid cohesion | 8.697793e-4 |
GO:0007127 | meiosis I | 8.905029e-4 |
GO:0019101 | female somatic sex determination | 8.908267e-4 |
GO:0042703 | menstruation | 8.908267e-4 |
GO:0035304 | regulation of protein dephosphorylation | 9.301070e-4 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 9.325608e-4 |
GO:0032792 | negative regulation of CREB transcription factor activity | 9.426045e-4 |
GO:0051016 | barbed-end actin filament capping | 9.662603e-4 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 9.808199e-4 |
GO:0010591 | regulation of lamellipodium assembly | 9.893401e-4 |
GO:0006400 | tRNA modification | 9.897815e-4 |
GO:0002002 | regulation of angiotensin levels in blood | 1.001498e-3 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.005993e-3 |
GO:0046069 | cGMP catabolic process | 1.011519e-3 |
GO:0046102 | inosine metabolic process | 1.030189e-3 |
GO:0060179 | male mating behavior | 1.039024e-3 |
GO:0097039 | protein linear polyubiquitination | 1.043430e-3 |
GO:0046730 | induction of host immune response by virus | 1.075004e-3 |
GO:0042069 | regulation of catecholamine metabolic process | 1.092122e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.093621e-3 |
GO:0050881 | musculoskeletal movement | 1.100059e-3 |
GO:0048205 | COPI coating of Golgi vesicle | 1.120270e-3 |
GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 1.147556e-3 |
GO:0060547 | negative regulation of necrotic cell death | 1.149478e-3 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 1.154660e-3 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 1.195380e-3 |
GO:0006998 | nuclear envelope organization | 1.204860e-3 |
GO:0001909 | leukocyte mediated cytotoxicity | 1.209576e-3 |
GO:0090281 | negative regulation of calcium ion import | 1.272860e-3 |
GO:0071584 | negative regulation of zinc ion import | 1.272860e-3 |
GO:0030311 | poly-N-acetyllactosamine biosynthetic process | 1.272860e-3 |
GO:0048318 | axial mesoderm development | 1.318844e-3 |
GO:0007614 | short-term memory | 1.324680e-3 |
GO:0043097 | pyrimidine nucleoside salvage | 1.329972e-3 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 1.348917e-3 |
GO:2000077 | negative regulation of type B pancreatic cell development | 1.348917e-3 |
GO:0018277 | protein deamination | 1.348917e-3 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.378306e-3 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 1.401493e-3 |
GO:0001835 | blastocyst hatching | 1.401493e-3 |
GO:0035308 | negative regulation of protein dephosphorylation | 1.413802e-3 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 1.417281e-3 |
GO:0070634 | transepithelial ammonium transport | 1.430414e-3 |
GO:0060669 | embryonic placenta morphogenesis | 1.439862e-3 |
GO:0019402 | galactitol metabolic process | 1.479434e-3 |
GO:0008216 | spermidine metabolic process | 1.479434e-3 |
GO:0021707 | cerebellar granule cell differentiation | 1.504877e-3 |
GO:0085018 | maintenance of symbiont-containing vacuole via substance secreted by host | 1.510738e-3 |
GO:0035378 | carbon dioxide transmembrane transport | 1.510738e-3 |
GO:0035377 | transepithelial water transport | 1.510738e-3 |
GO:0008295 | spermidine biosynthetic process | 1.510738e-3 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 1.510738e-3 |
GO:0032782 | bile acid secretion | 1.510738e-3 |
GO:0015696 | ammonium transport | 1.515781e-3 |
GO:0060375 | regulation of mast cell differentiation | 1.538555e-3 |
GO:0097037 | heme export | 1.540255e-3 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 1.540255e-3 |
GO:0018916 | nitrobenzene metabolic process | 1.540255e-3 |
GO:0006696 | ergosterol biosynthetic process | 1.540255e-3 |
GO:0034635 | glutathione transport | 1.552143e-3 |
GO:0001830 | trophectodermal cell fate commitment | 1.552143e-3 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.562693e-3 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.580550e-3 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.580671e-3 |
GO:0003416 | endochondral bone growth | 1.596134e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 1.620153e-3 |
GO:0006560 | proline metabolic process | 1.663178e-3 |
GO:0030187 | melatonin biosynthetic process | 1.673548e-3 |
GO:0035767 | endothelial cell chemotaxis | 1.682372e-3 |
GO:0090311 | regulation of protein deacetylation | 1.685992e-3 |
GO:0060996 | dendritic spine development | 1.711817e-3 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 1.715560e-3 |
GO:0070309 | lens fiber cell morphogenesis | 1.716135e-3 |
GO:0014037 | Schwann cell differentiation | 1.717905e-3 |
GO:0051320 | S phase | 1.750685e-3 |
GO:0006290 | pyrimidine dimer repair | 1.773021e-3 |
GO:0002067 | glandular epithelial cell differentiation | 1.799717e-3 |
GO:0010891 | negative regulation of sequestering of triglyceride | 1.806547e-3 |
GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity | 1.859275e-3 |
GO:0046813 | virion attachment, binding of host cell surface receptor | 1.868505e-3 |
GO:0046103 | inosine biosynthetic process | 1.928856e-3 |
GO:0045064 | T-helper 2 cell differentiation | 1.928856e-3 |
GO:0002315 | marginal zone B cell differentiation | 1.928856e-3 |
GO:0006154 | adenosine catabolic process | 1.928856e-3 |
GO:0048343 | paraxial mesodermal cell fate commitment | 1.934306e-3 |
GO:0015874 | norepinephrine transport | 1.934306e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.935167e-3 |
GO:0042255 | ribosome assembly | 1.936637e-3 |
GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 1.953763e-3 |
GO:0051865 | protein autoubiquitination | 1.959471e-3 |
GO:0071421 | manganese ion transmembrane transport | 1.971519e-3 |
GO:0030826 | regulation of cGMP biosynthetic process | 1.981362e-3 |
GO:0071496 | cellular response to external stimulus | 1.981736e-3 |
GO:0030903 | notochord development | 2.007122e-3 |
GO:0050779 | RNA destabilization | 2.110076e-3 |
GO:0035518 | histone H2A monoubiquitination | 2.116900e-3 |
GO:0000089 | mitotic metaphase | 2.126739e-3 |
GO:0006090 | pyruvate metabolic process | 2.223841e-3 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 2.236321e-3 |
GO:0031284 | positive regulation of guanylate cyclase activity | 2.236321e-3 |
GO:0043174 | nucleoside salvage | 2.263628e-3 |
GO:0033683 | nucleotide-excision repair, DNA incision | 2.270479e-3 |
GO:0044236 | multicellular organismal metabolic process | 2.335133e-3 |
GO:0045948 | positive regulation of translational initiation | 2.338979e-3 |
GO:0007184 | SMAD protein import into nucleus | 2.353658e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006351 | transcription, DNA-dependent | 1.383099e-8 |
GO:0032774 | RNA biosynthetic process | 1.982967e-8 |
GO:0046847 | filopodium assembly | 3.784843e-8 |
GO:0045814 | negative regulation of gene expression, epigenetic | 2.156744e-7 |
GO:0045922 | negative regulation of fatty acid metabolic process | 2.332677e-7 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.567414e-7 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 3.220532e-7 |
GO:0030035 | microspike assembly | 3.365513e-7 |
GO:0034227 | tRNA thio-modification | 3.857285e-7 |
GO:0045792 | negative regulation of cell size | 3.954850e-7 |
GO:0010467 | gene expression | 4.746834e-7 |
GO:0006346 | methylation-dependent chromatin silencing | 1.426943e-6 |
GO:0032007 | negative regulation of TOR signaling cascade | 1.790440e-6 |
GO:0046785 | microtubule polymerization | 1.983779e-6 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.221566e-6 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.350824e-6 |
GO:0001885 | endothelial cell development | 3.130311e-6 |
GO:0001892 | embryonic placenta development | 5.327106e-6 |
GO:0022009 | central nervous system vasculogenesis | 5.356954e-6 |
GO:0048255 | mRNA stabilization | 6.350466e-6 |
GO:0034142 | toll-like receptor 4 signaling pathway | 6.554619e-6 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 6.673356e-6 |
GO:0002221 | pattern recognition receptor signaling pathway | 9.215430e-6 |
GO:0045908 | negative regulation of vasodilation | 9.568868e-6 |
GO:0034505 | tooth mineralization | 1.468279e-5 |
GO:0002758 | innate immune response-activating signal transduction | 1.854845e-5 |
GO:0030219 | megakaryocyte differentiation | 1.882964e-5 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 1.998772e-5 |
GO:0090083 | regulation of inclusion body assembly | 2.109286e-5 |
GO:0090084 | negative regulation of inclusion body assembly | 2.182729e-5 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 2.517166e-5 |
GO:0002224 | toll-like receptor signaling pathway | 3.137801e-5 |
GO:0060712 | spongiotrophoblast layer development | 3.380260e-5 |
GO:0002218 | activation of innate immune response | 3.491541e-5 |
GO:0007288 | sperm axoneme assembly | 3.533215e-5 |
GO:0035313 | wound healing, spreading of epidermal cells | 3.755544e-5 |
GO:0032776 | DNA methylation on cytosine | 3.869937e-5 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 3.957363e-5 |
GO:0018022 | peptidyl-lysine methylation | 4.264442e-5 |
GO:0010312 | detoxification of zinc ion | 4.282926e-5 |
GO:0090234 | regulation of kinetochore assembly | 4.783348e-5 |
GO:0090169 | regulation of spindle assembly | 4.783348e-5 |
GO:0010216 | maintenance of DNA methylation | 5.108377e-5 |
GO:0006558 | L-phenylalanine metabolic process | 5.108377e-5 |
GO:0014045 | establishment of endothelial blood-brain barrier | 5.166059e-5 |
GO:0090086 | negative regulation of protein deubiquitination | 5.167114e-5 |
GO:0009648 | photoperiodism | 5.218590e-5 |
GO:0046322 | negative regulation of fatty acid oxidation | 5.878922e-5 |
GO:0016070 | RNA metabolic process | 7.220839e-5 |
GO:0044319 | wound healing, spreading of cells | 7.222535e-5 |
GO:0045647 | negative regulation of erythrocyte differentiation | 8.892322e-5 |
GO:0032012 | regulation of ARF protein signal transduction | 9.138330e-5 |
GO:0043153 | entrainment of circadian clock by photoperiod | 1.029821e-4 |
GO:0043314 | negative regulation of neutrophil degranulation | 1.150862e-4 |
GO:0043301 | negative regulation of leukocyte degranulation | 1.188198e-4 |
GO:0045064 | T-helper 2 cell differentiation | 1.211470e-4 |
GO:0002098 | tRNA wobble uridine modification | 1.239559e-4 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.264807e-4 |
GO:0050685 | positive regulation of mRNA processing | 1.289193e-4 |
GO:0006559 | L-phenylalanine catabolic process | 1.343357e-4 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 1.384780e-4 |
GO:0001957 | intramembranous ossification | 1.421590e-4 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 1.508502e-4 |
GO:0002268 | follicular dendritic cell differentiation | 1.508502e-4 |
GO:0006342 | chromatin silencing | 1.566454e-4 |
GO:0006268 | DNA unwinding involved in replication | 1.590099e-4 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 1.593356e-4 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.623513e-4 |
GO:0060066 | oviduct development | 1.623513e-4 |
GO:0043320 | natural killer cell degranulation | 1.627369e-4 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 1.651641e-4 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.752367e-4 |
GO:0045948 | positive regulation of translational initiation | 1.762377e-4 |
GO:0018065 | protein-cofactor linkage | 2.018348e-4 |
GO:2000015 | regulation of determination of dorsal identity | 2.056899e-4 |
GO:0071506 | cellular response to mycophenolic acid | 2.108455e-4 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 2.108455e-4 |
GO:0060010 | Sertoli cell fate commitment | 2.108455e-4 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 2.141408e-4 |
GO:0033590 | response to cobalamin | 2.141408e-4 |
GO:0007144 | female meiosis I | 2.141408e-4 |
GO:0018195 | peptidyl-arginine modification | 2.289678e-4 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 2.506618e-4 |
GO:0001835 | blastocyst hatching | 2.535244e-4 |
GO:0018198 | peptidyl-cysteine modification | 2.666544e-4 |
GO:0021877 | forebrain neuron fate commitment | 2.669934e-4 |
GO:0034446 | substrate adhesion-dependent cell spreading | 2.672646e-4 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 2.680992e-4 |
GO:0008295 | spermidine biosynthetic process | 2.750419e-4 |
GO:0090304 | nucleic acid metabolic process | 2.804562e-4 |
GO:0000045 | autophagic vacuole assembly | 2.863983e-4 |
GO:0045987 | positive regulation of smooth muscle contraction | 2.887805e-4 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 3.137128e-4 |
GO:0018205 | peptidyl-lysine modification | 3.361224e-4 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 3.482159e-4 |
GO:0017156 | calcium ion-dependent exocytosis | 3.485974e-4 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 3.771538e-4 |
GO:0033159 | negative regulation of protein import into nucleus, translocation | 3.783650e-4 |
GO:0035021 | negative regulation of Rac protein signal transduction | 3.800839e-4 |
GO:0007412 | axon target recognition | 3.800839e-4 |
GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation | 3.926037e-4 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 3.926037e-4 |
GO:0060709 | glycogen cell development involved in embryonic placenta development | 4.116515e-4 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 4.225398e-4 |
GO:0032964 | collagen biosynthetic process | 4.464065e-4 |
GO:0031109 | microtubule polymerization or depolymerization | 4.705836e-4 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 4.919669e-4 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 4.919669e-4 |
GO:0018023 | peptidyl-lysine trimethylation | 4.919669e-4 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 4.919669e-4 |
GO:0051103 | DNA ligation involved in DNA repair | 5.146100e-4 |
GO:0006266 | DNA ligation | 5.190791e-4 |
GO:0010984 | regulation of lipoprotein particle clearance | 5.248770e-4 |
GO:0043313 | regulation of neutrophil degranulation | 5.262705e-4 |
GO:0016567 | protein ubiquitination | 5.559537e-4 |
GO:0021695 | cerebellar cortex development | 5.781014e-4 |
GO:0006094 | gluconeogenesis | 5.823243e-4 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 6.244251e-4 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 6.244251e-4 |
GO:0070925 | organelle assembly | 6.557350e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 6.684840e-4 |
GO:0014056 | regulation of acetylcholine secretion | 6.707435e-4 |
GO:0034382 | chylomicron remnant clearance | 6.731357e-4 |
GO:0006363 | termination of RNA polymerase I transcription | 6.789401e-4 |
GO:0001829 | trophectodermal cell differentiation | 6.967352e-4 |
GO:0072054 | renal outer medulla development | 6.980526e-4 |
GO:0035246 | peptidyl-arginine N-methylation | 7.155623e-4 |
GO:0021681 | cerebellar granular layer development | 7.456043e-4 |
GO:0046039 | GTP metabolic process | 7.539761e-4 |
GO:0034959 | endothelin maturation | 7.573316e-4 |
GO:0010814 | substance P catabolic process | 7.573316e-4 |
GO:0010816 | calcitonin catabolic process | 7.573316e-4 |
GO:0018216 | peptidyl-arginine methylation | 7.621655e-4 |
GO:0033119 | negative regulation of RNA splicing | 7.760353e-4 |
GO:0000212 | meiotic spindle organization | 8.169090e-4 |
GO:0045446 | endothelial cell differentiation | 8.183568e-4 |
GO:0001570 | vasculogenesis | 8.233191e-4 |
GO:0046940 | nucleoside monophosphate phosphorylation | 8.641016e-4 |
GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway | 8.641016e-4 |
GO:0035912 | dorsal aorta morphogenesis | 8.641016e-4 |
GO:0030038 | contractile actin filament bundle assembly | 8.641016e-4 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 8.667959e-4 |
GO:0023035 | CD40 signaling pathway | 8.667959e-4 |
GO:0008594 | photoreceptor cell morphogenesis | 8.667959e-4 |
GO:0035886 | vascular smooth muscle cell differentiation | 8.738357e-4 |
GO:0061084 | negative regulation of protein refolding | 8.943463e-4 |
GO:0010891 | negative regulation of sequestering of triglyceride | 8.976396e-4 |
GO:0060484 | lung-associated mesenchyme development | 9.129893e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 9.171312e-4 |
GO:0043243 | positive regulation of protein complex disassembly | 9.287349e-4 |
GO:0061028 | establishment of endothelial barrier | 9.623993e-4 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 9.746720e-4 |
GO:0061001 | regulation of dendritic spine morphogenesis | 9.789144e-4 |
GO:0007143 | female meiosis | 1.024207e-3 |
GO:0035813 | regulation of renal sodium excretion | 1.030171e-3 |
GO:0072053 | renal inner medulla development | 1.064743e-3 |
GO:0016236 | macroautophagy | 1.070185e-3 |
GO:0050684 | regulation of mRNA processing | 1.078990e-3 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 1.113793e-3 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.113793e-3 |
GO:0016568 | chromatin modification | 1.117152e-3 |
GO:0042538 | hyperosmotic salinity response | 1.121042e-3 |
GO:0050779 | RNA destabilization | 1.142520e-3 |
GO:0061013 | regulation of mRNA catabolic process | 1.150296e-3 |
GO:0044062 | regulation of excretion | 1.150296e-3 |
GO:0018199 | peptidyl-glutamine modification | 1.155679e-3 |
GO:0032446 | protein modification by small protein conjugation | 1.173936e-3 |
GO:0001825 | blastocyst formation | 1.235353e-3 |
GO:0009059 | macromolecule biosynthetic process | 1.267507e-3 |
GO:0007129 | synapsis | 1.272660e-3 |
GO:0070192 | chromosome organization involved in meiosis | 1.273312e-3 |
GO:0090116 | C-5 methylation of cytosine | 1.352416e-3 |
GO:0072284 | metanephric S-shaped body morphogenesis | 1.352416e-3 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 1.352416e-3 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 1.352416e-3 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 1.383748e-3 |
GO:0001890 | placenta development | 1.396078e-3 |
GO:0006184 | GTP catabolic process | 1.410443e-3 |
GO:0018293 | protein-FAD linkage | 1.417611e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 1.417611e-3 |
GO:0010889 | regulation of sequestering of triglyceride | 1.435054e-3 |
GO:0016188 | synaptic vesicle maturation | 1.444796e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 1.447378e-3 |
GO:0045819 | positive regulation of glycogen catabolic process | 1.495920e-3 |
GO:0032508 | DNA duplex unwinding | 1.508289e-3 |
GO:0003158 | endothelium development | 1.524480e-3 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 1.532815e-3 |
GO:0060534 | trachea cartilage development | 1.554601e-3 |
GO:0001886 | endothelial cell morphogenesis | 1.556124e-3 |
GO:0050995 | negative regulation of lipid catabolic process | 1.567004e-3 |
GO:0035855 | megakaryocyte development | 1.570027e-3 |
GO:0048368 | lateral mesoderm development | 1.570027e-3 |
GO:0006572 | tyrosine catabolic process | 1.674680e-3 |
GO:0034969 | histone arginine methylation | 1.693345e-3 |
GO:0060012 | synaptic transmission, glycinergic | 1.714755e-3 |
GO:0046755 | non-lytic virus budding | 1.714755e-3 |
GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine | 1.714755e-3 |
GO:0002077 | acrosome matrix dispersal | 1.714755e-3 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 1.813991e-3 |
GO:0001834 | trophectodermal cell proliferation | 1.813991e-3 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 1.814195e-3 |
GO:0060976 | coronary vasculature development | 1.849924e-3 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 1.852743e-3 |
GO:0051276 | chromosome organization | 1.873226e-3 |
GO:0070286 | axonemal dynein complex assembly | 1.882138e-3 |
GO:0071529 | cementum mineralization | 1.882138e-3 |
GO:0006449 | regulation of translational termination | 1.882138e-3 |
GO:0035082 | axoneme assembly | 1.931471e-3 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 1.932110e-3 |
GO:0010452 | histone H3-K36 methylation | 2.046709e-3 |
GO:0070383 | DNA cytosine deamination | 2.101485e-3 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 2.101485e-3 |
GO:0010529 | negative regulation of transposition | 2.101485e-3 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 2.101485e-3 |
GO:0060047 | heart contraction | 2.109192e-3 |
GO:0071299 | cellular response to vitamin A | 2.117390e-3 |
GO:0002432 | granuloma formation | 2.125061e-3 |
GO:0033002 | muscle cell proliferation | 2.149151e-3 |
GO:0035329 | hippo signaling cascade | 2.155467e-3 |
GO:0008078 | mesodermal cell migration | 2.201901e-3 |
GO:0038007 | netrin-activated signaling pathway | 2.241848e-3 |
GO:0051013 | microtubule severing | 2.241848e-3 |
GO:0070474 | positive regulation of uterine smooth muscle contraction | 2.358594e-3 |
GO:0061034 | olfactory bulb mitral cell layer development | 2.358594e-3 |
GO:0032922 | circadian regulation of gene expression | 2.367816e-3 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 2.371050e-3 |
GO:0030865 | cortical cytoskeleton organization | 2.401436e-3 |
GO:0043401 | steroid hormone mediated signaling pathway | 2.479392e-3 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 2.535567e-3 |
GO:0010458 | exit from mitosis | 2.535567e-3 |
GO:0072061 | inner medullary collecting duct development | 2.617580e-3 |
GO:2000017 | positive regulation of determination of dorsal identity | 2.617580e-3 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 2.617580e-3 |
GO:0072060 | outer medullary collecting duct development | 2.617580e-3 |
GO:0046882 | negative regulation of follicle-stimulating hormone secretion | 2.617580e-3 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 2.617580e-3 |
GO:0072109 | glomerular mesangium development | 2.651361e-3 |
GO:0007340 | acrosome reaction | 2.721628e-3 |
GO:0048295 | positive regulation of isotype switching to IgE isotypes | 2.737535e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 2.737535e-3 |
GO:0033158 | regulation of protein import into nucleus, translocation | 2.784428e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.804567e-3 |
GO:0072070 | loop of Henle development | 2.808120e-3 |
GO:0051586 | positive regulation of dopamine uptake | 2.863584e-3 |
GO:0035659 | Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells | 2.863584e-3 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 2.863584e-3 |
GO:0014719 | satellite cell activation | 2.863584e-3 |
GO:0042304 | regulation of fatty acid biosynthetic process | 2.963221e-3 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 2.969716e-3 |
GO:0050994 | regulation of lipid catabolic process | 3.060329e-3 |
GO:0032392 | DNA geometric change | 3.100972e-3 |
GO:0006325 | chromatin organization | 3.112957e-3 |
GO:0097039 | protein linear polyubiquitination | 3.145354e-3 |
GO:0040029 | regulation of gene expression, epigenetic | 3.152018e-3 |
GO:0018105 | peptidyl-serine phosphorylation | 3.194642e-3 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 3.218319e-3 |
GO:0060385 | axonogenesis involved in innervation | 3.218319e-3 |
GO:0015887 | pantothenate transmembrane transport | 3.218319e-3 |
GO:0015878 | biotin transport | 3.218319e-3 |
GO:0006409 | tRNA export from nucleus | 3.218319e-3 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 3.370090e-3 |
GO:0031129 | inductive cell-cell signaling | 3.370090e-3 |
GO:0006756 | AMP phosphorylation | 3.370090e-3 |
GO:0043968 | histone H2A acetylation | 3.403567e-3 |
GO:0071300 | cellular response to retinoic acid | 3.420373e-3 |
GO:0010288 | response to lead ion | 3.536331e-3 |
GO:0046590 | embryonic leg morphogenesis | 3.547866e-3 |
GO:0008050 | female courtship behavior | 3.547866e-3 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 3.599703e-3 |
GO:0060419 | heart growth | 3.612777e-3 |
GO:0000089 | mitotic metaphase | 3.635000e-3 |
GO:0055017 | cardiac muscle tissue growth | 3.662747e-3 |
GO:0071321 | cellular response to cGMP | 3.674942e-3 |
GO:0060048 | cardiac muscle contraction | 3.733842e-3 |
GO:0010887 | negative regulation of cholesterol storage | 3.762301e-3 |
GO:0060461 | right lung morphogenesis | 3.768874e-3 |
GO:0090131 | mesenchyme migration | 3.768874e-3 |
GO:0014822 | detection of wounding | 3.768874e-3 |
GO:0060446 | branching involved in open tracheal system development | 3.768874e-3 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 3.768874e-3 |
GO:0048371 | lateral mesodermal cell differentiation | 3.768874e-3 |
GO:0042373 | vitamin K metabolic process | 3.862539e-3 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 3.899702e-3 |
GO:0033233 | regulation of protein sumoylation | 3.945665e-3 |
GO:0072205 | metanephric collecting duct development | 3.945665e-3 |
GO:0051693 | actin filament capping | 4.083156e-3 |
GO:0007509 | mesoderm migration involved in gastrulation | 4.162681e-3 |
GO:0061002 | negative regulation of dendritic spine morphogenesis | 4.198598e-3 |
GO:0010565 | regulation of cellular ketone metabolic process | 4.276841e-3 |
GO:0009798 | axis specification | 4.314787e-3 |
GO:0060535 | trachea cartilage morphogenesis | 4.348128e-3 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 4.348128e-3 |
GO:0045916 | negative regulation of complement activation | 4.352044e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 4.352044e-3 |
GO:0021697 | cerebellar cortex formation | 4.392561e-3 |
GO:0060343 | trabecula formation | 4.615522e-3 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 4.661700e-3 |
GO:0031507 | heterochromatin formation | 4.690402e-3 |
GO:0042268 | regulation of cytolysis | 4.710383e-3 |
GO:0016926 | protein desumoylation | 4.710383e-3 |
GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway | 4.769309e-3 |
GO:0021707 | cerebellar granule cell differentiation | 4.844770e-3 |
GO:0008535 | respiratory chain complex IV assembly | 4.990679e-3 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 4.990679e-3 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 5.117370e-3 |
GO:0030421 | defecation | 5.117370e-3 |
GO:0008216 | spermidine metabolic process | 5.117370e-3 |
GO:0008063 | Toll signaling pathway | 5.117370e-3 |
GO:0051176 | positive regulation of sulfur metabolic process | 5.193896e-3 |
GO:0051451 | myoblast migration | 5.193896e-3 |
GO:0035441 | cell migration involved in vasculogenesis | 5.193896e-3 |
GO:0043300 | regulation of leukocyte degranulation | 5.220103e-3 |
GO:0090224 | regulation of spindle organization | 5.257895e-3 |
GO:0006513 | protein monoubiquitination | 5.407891e-3 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 5.481174e-3 |
GO:0051323 | metaphase | 5.529872e-3 |
GO:0051238 | sequestering of metal ion | 5.681804e-3 |
GO:0097012 | response to granulocyte macrophage colony-stimulating factor stimulus | 5.681804e-3 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 5.739874e-3 |
GO:2000383 | regulation of ectoderm development | 5.952500e-3 |
GO:0051252 | regulation of RNA metabolic process | 6.097924e-3 |
GO:0072110 | glomerular mesangial cell proliferation | 6.135985e-3 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 6.135985e-3 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 6.160893e-3 |
GO:0046929 | negative regulation of neurotransmitter secretion | 6.208343e-3 |
GO:0014040 | positive regulation of Schwann cell differentiation | 6.208343e-3 |
GO:0006685 | sphingomyelin catabolic process | 6.208343e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 6.253376e-3 |
GO:0046320 | regulation of fatty acid oxidation | 6.433359e-3 |
GO:0016090 | prenol metabolic process | 6.464211e-3 |
GO:0051725 | protein de-ADP-ribosylation | 6.549966e-3 |
GO:0070079 | histone H4-R3 demethylation | 6.549966e-3 |
GO:0070078 | histone H3-R2 demethylation | 6.549966e-3 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 6.549966e-3 |
GO:0000722 | telomere maintenance via recombination | 6.549966e-3 |
GO:0060482 | lobar bronchus development | 6.566937e-3 |
GO:0032119 | sequestering of zinc ion | 6.684441e-3 |
GO:0010468 | regulation of gene expression | 6.710354e-3 |
GO:0072236 | metanephric loop of Henle development | 6.842263e-3 |
GO:0071422 | succinate transmembrane transport | 6.930547e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 6.930547e-3 |
GO:0035269 | protein O-linked mannosylation | 6.930547e-3 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 6.973811e-3 |
GO:0016574 | histone ubiquitination | 7.236604e-3 |
GO:0032006 | regulation of TOR signaling cascade | 7.297150e-3 |
GO:0048227 | plasma membrane to endosome transport | 7.306280e-3 |
GO:0046604 | positive regulation of mitotic centrosome separation | 7.306280e-3 |
GO:0065002 | intracellular protein transmembrane transport | 7.306280e-3 |
GO:0032065 | cortical protein anchoring | 7.306280e-3 |
GO:0021528 | commissural neuron differentiation in spinal cord | 7.306280e-3 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 7.356229e-3 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 7.356229e-3 |
GO:0051026 | chiasma assembly | 7.356229e-3 |
GO:0006546 | glycine catabolic process | 7.356229e-3 |
GO:2000426 | negative regulation of apoptotic cell clearance | 7.383776e-3 |
GO:0033147 | negative regulation of estrogen receptor signaling pathway | 7.383776e-3 |
GO:0071480 | cellular response to gamma radiation | 7.436457e-3 |
GO:0072164 | mesonephric tubule development | 7.667721e-3 |
GO:0019217 | regulation of fatty acid metabolic process | 7.674399e-3 |
GO:0046967 | cytosol to ER transport | 7.763099e-3 |
GO:0035611 | protein branching point deglutamylation | 7.763099e-3 |
GO:0019060 | intracellular transport of viral proteins in host cell | 7.763099e-3 |
GO:0034134 | toll-like receptor 2 signaling pathway | 7.763099e-3 |
GO:0043206 | fibril organization | 7.841618e-3 |
GO:0042267 | natural killer cell mediated cytotoxicity | 8.040959e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 8.045365e-3 |
GO:0060038 | cardiac muscle cell proliferation | 8.046460e-3 |
GO:0002002 | regulation of angiotensin levels in blood | 8.046659e-3 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 8.046659e-3 |
GO:0046939 | nucleotide phosphorylation | 8.114979e-3 |
GO:0031365 | N-terminal protein amino acid modification | 8.131209e-3 |
GO:0060997 | dendritic spine morphogenesis | 8.164857e-3 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 8.232239e-3 |
GO:0015884 | folic acid transport | 8.357986e-3 |
GO:0051639 | actin filament network formation | 8.466740e-3 |
GO:0045905 | positive regulation of translational termination | 8.466740e-3 |
GO:2000384 | negative regulation of ectoderm development | 8.466740e-3 |
GO:0006452 | translational frameshifting | 8.466740e-3 |
GO:0045343 | regulation of MHC class I biosynthetic process | 8.466740e-3 |
GO:0045901 | positive regulation of translational elongation | 8.466740e-3 |
GO:0061383 | trabecula morphogenesis | 8.482957e-3 |
GO:0018193 | peptidyl-amino acid modification | 8.534465e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 8.644945e-3 |
GO:0045112 | integrin biosynthetic process | 8.727476e-3 |
GO:0060346 | bone trabecula formation | 8.816831e-3 |
GO:0045920 | negative regulation of exocytosis | 8.930372e-3 |
GO:0031331 | positive regulation of cellular catabolic process | 9.084410e-3 |
GO:0022406 | membrane docking | 9.111513e-3 |
GO:0007619 | courtship behavior | 9.152667e-3 |
GO:0010950 | positive regulation of endopeptidase activity | 9.255239e-3 |
GO:0021696 | cerebellar cortex morphogenesis | 9.324438e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 9.375119e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 9.375119e-3 |
GO:0007028 | cytoplasm organization | 9.375119e-3 |
GO:0090045 | positive regulation of deacetylase activity | 9.439651e-3 |
GO:0070831 | basement membrane assembly | 9.439651e-3 |
GO:0006930 | substrate-dependent cell migration, cell extension | 9.439651e-3 |
GO:0006391 | transcription initiation from mitochondrial promoter | 9.439651e-3 |
GO:0048285 | organelle fission | 9.473527e-3 |
GO:0072074 | kidney mesenchyme development | 9.646339e-3 |
GO:0090002 | establishment of protein localization in plasma membrane | 9.799669e-3 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 9.799669e-3 |
GO:0031272 | regulation of pseudopodium assembly | 9.927598e-3 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 9.927711e-3 |
GO:0010896 | regulation of triglyceride catabolic process | 9.975564e-3 |
GO:0007051 | spindle organization | 1.020429e-2 |
GO:0032312 | regulation of ARF GTPase activity | 1.025445e-2 |
GO:0022614 | membrane to membrane docking | 1.032666e-2 |
GO:0002827 | positive regulation of T-helper 1 type immune response | 1.032666e-2 |
GO:0030261 | chromosome condensation | 1.041244e-2 |
GO:0060180 | female mating behavior | 1.042964e-2 |
GO:0033083 | regulation of immature T cell proliferation | 1.042964e-2 |
GO:0070836 | caveola assembly | 1.045727e-2 |
GO:0032613 | interleukin-10 production | 1.045727e-2 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 1.050761e-2 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 1.050761e-2 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 1.050761e-2 |
GO:0072075 | metanephric mesenchyme development | 1.052305e-2 |
GO:0046339 | diacylglycerol metabolic process | 1.062613e-2 |
GO:0016458 | gene silencing | 1.063256e-2 |
GO:0030878 | thyroid gland development | 1.075358e-2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.101817e-2 |
GO:0043045 | DNA methylation involved in embryo development | 1.143014e-2 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.143014e-2 |
GO:0046685 | response to arsenic-containing substance | 1.153385e-2 |
GO:0090150 | establishment of protein localization in membrane | 1.159253e-2 |
GO:0051301 | cell division | 1.199280e-2 |
GO:0043088 | regulation of Cdc42 GTPase activity | 1.203659e-2 |
GO:0046341 | CDP-diacylglycerol metabolic process | 1.209027e-2 |
GO:0000729 | DNA double-strand break processing | 1.209027e-2 |
GO:0031998 | regulation of fatty acid beta-oxidation | 1.228343e-2 |
GO:0070305 | response to cGMP | 1.228500e-2 |
GO:0008612 | peptidyl-lysine modification to hypusine | 1.228500e-2 |
GO:0000087 | M phase of mitotic cell cycle | 1.231544e-2 |
GO:0010878 | cholesterol storage | 1.256585e-2 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 1.256585e-2 |
GO:0033566 | gamma-tubulin complex localization | 1.256585e-2 |
GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 1.257107e-2 |
GO:0045833 | negative regulation of lipid metabolic process | 1.275706e-2 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 1.307269e-2 |
GO:0006657 | CDP-choline pathway | 1.307333e-2 |
GO:0045933 | positive regulation of muscle contraction | 1.317288e-2 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.341495e-2 |
GO:0051254 | positive regulation of RNA metabolic process | 1.347959e-2 |
GO:0071636 | positive regulation of transforming growth factor beta production | 1.360727e-2 |
GO:0043201 | response to leucine | 1.361085e-2 |
GO:0061088 | regulation of sequestering of zinc ion | 1.361085e-2 |
GO:0021683 | cerebellar granular layer morphogenesis | 1.389658e-2 |
GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 1.399866e-2 |
GO:0007183 | SMAD protein complex assembly | 1.399866e-2 |
GO:0006778 | porphyrin-containing compound metabolic process | 1.403045e-2 |
GO:0090130 | tissue migration | 1.403243e-2 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 1.406855e-2 |
GO:0043488 | regulation of mRNA stability | 1.407644e-2 |
GO:0043949 | regulation of cAMP-mediated signaling | 1.408293e-2 |
GO:0060711 | labyrinthine layer development | 1.408691e-2 |
GO:0051220 | cytoplasmic sequestering of protein | 1.412390e-2 |
GO:2000772 | regulation of cellular senescence | 1.415053e-2 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 1.415053e-2 |
GO:0033013 | tetrapyrrole metabolic process | 1.425990e-2 |
GO:0007614 | short-term memory | 1.426379e-2 |
GO:0006213 | pyrimidine nucleoside metabolic process | 1.427973e-2 |
GO:0006288 | base-excision repair, DNA ligation | 1.445400e-2 |
GO:0071260 | cellular response to mechanical stimulus | 1.467582e-2 |
GO:0042275 | error-free postreplication DNA repair | 1.490737e-2 |
GO:0035520 | monoubiquitinated protein deubiquitination | 1.490737e-2 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 1.490737e-2 |
GO:0035461 | vitamin transmembrane transport | 1.490737e-2 |
GO:0031508 | centromeric heterochromatin formation | 1.490737e-2 |
GO:0072003 | kidney rudiment formation | 1.501243e-2 |
GO:0060177 | regulation of angiotensin metabolic process | 1.505286e-2 |
GO:0048477 | oogenesis | 1.508557e-2 |
GO:0007127 | meiosis I | 1.548342e-2 |
GO:0032098 | regulation of appetite | 1.559362e-2 |
GO:0090280 | positive regulation of calcium ion import | 1.559460e-2 |
GO:0010388 | cullin deneddylation | 1.559460e-2 |
GO:0071316 | cellular response to nicotine | 1.559460e-2 |
GO:0060299 | negative regulation of sarcomere organization | 1.582327e-2 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 1.582327e-2 |
GO:0070345 | negative regulation of fat cell proliferation | 1.582327e-2 |
GO:0042840 | D-glucuronate catabolic process | 1.582327e-2 |
GO:0070086 | ubiquitin-dependent endocytosis | 1.582327e-2 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 1.582327e-2 |
GO:0042703 | menstruation | 1.582327e-2 |
GO:0009234 | menaquinone biosynthetic process | 1.582327e-2 |
GO:0032782 | bile acid secretion | 1.582327e-2 |
GO:0019101 | female somatic sex determination | 1.582327e-2 |
GO:0003096 | renal sodium ion transport | 1.582327e-2 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 1.582327e-2 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 1.606751e-2 |
GO:0051156 | glucose 6-phosphate metabolic process | 1.629418e-2 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.629418e-2 |
GO:0043487 | regulation of RNA stability | 1.631245e-2 |
GO:0000738 | DNA catabolic process, exonucleolytic | 1.651965e-2 |
GO:0007386 | compartment pattern specification | 1.651965e-2 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.651965e-2 |
GO:0001955 | blood vessel maturation | 1.651965e-2 |
GO:0033210 | leptin-mediated signaling pathway | 1.658666e-2 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 1.658666e-2 |
GO:0046452 | dihydrofolate metabolic process | 1.658666e-2 |